Availability of multiple sclerosis (MS) therapies provides substantial value to the currently healthy (who may contract MS in the future), particularly when treatment is fully covered by insurance.
A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Regardless of the cause of bias, more awareness and scrutiny are needed when utilizing cost-effectiveness studies for healthcare decision making.
A limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.
With a rapid shift to telehealth during the coronavirus disease 2019 (COVID-19) pandemic, clinicians, health care organizations, and policy makers must consider and address patients’ evolving needs, concerns, and expectations.
Bundled cardioprotective medications with simplified delivery reduced the risk of hospitalization for myocardial infarction or stroke among patients at high risk.
A study to assess clinician attitudes and experiences after participating in a New York City cardiovascular disease focused quality recognition and financial incentive program using health information technology.
The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.
This prospective trial suggests that specialized care coordination and health counseling for patients coping with advanced stages of 4 life-limiting illnesses can be beneficial.
Predictive modeling can be used to identify disabled Medicaid beneficiaries at high risk of future hospitalizations who could benefit from appropriate interventions.
In a survey of patients and visitors to a large academic medical center, middle-income respondents with private insurance reported more cost-related delays in care than those with public insurance.
Implementation of the Quality Blue Primary Care program in Louisiana was associated with a shift in primary care delivery and reductions in overall cost.
Focusing on quality and quality measurements has the potential to reduce costs, increase quality, and deliver more value to patients, consumers, and customers.
Oregon’s Medicaid accountable care organizations led to reductions in preventable hospital admissions, especially unscheduled admissions, among female beneficiaries aged 15 to 44 years.
Reducing inappropriate use of cardiac telemetry may improve the cost of care while maintaining patient safety.